• Home
  • Advertise
  • Contact Us
Thursday, January 28, 2021
No Result
View All Result
NEWSLETTER
LondonDailyPost.com
5 °c
London
4 ° Sat
2 ° Sun
4 ° Mon
6 ° Tue
  • UK News
  • World
  • Health
  • Business
  • Science
  • Tech
  • Entertainment
  • Sports
  • Lifestyle
  • Travel
  • Politics
  • UK News
  • World
  • Health
  • Business
  • Science
  • Tech
  • Entertainment
  • Sports
  • Lifestyle
  • Travel
  • Politics
No Result
View All Result
LondonDailyPost.com
No Result
View All Result
Home Health

Dalmia Healthcare starts clinical trial with its Ayurvedic composition to treat COVID-19

by Kevin Taylor
June 5, 2020
in Health
2 min read

New Delhi, June 04, 2020: Dalmia Healthcare, the healthcare division of Dalmia Group led by renowned industrialist Sanjay Dalmia, starts clinical trial to evaluate the efficacy and safety of polyherbal combination “Astha-15” for treatment of COVID-19. The Dalmia Centre for Research and Development (DCRD), R & D entity of Dalmia Group after years of extensive research, manufactured a polyherbal combination of 15 herbs called Astha-15, also mentioned in the Indian System of Medicine. Set regulatory guidelines of Informed Consent Declaration, Insurance Terms and EC approvals will be followed to conduct the Multi-centric, Phase III clinical trials. This phase III clinical trial has been registered on CTRI with reg. no. CTRI/2020/06/025590.

The study comes in the back of the Ministry of AYUSH last month recommending the use of herbal products like tea, spices, to overcome the pandemic. The polyherbal combination “Astha-15”, made available by the Group on March 16, has previously undergone a randomized double-blind, placebo-controlled study on patients, in speciality Govt. Hospital, Chennai, India. As per the double-blind study, the drug acts as a bronchodilator, decongestant, anti-inflammatory, lung detoxifier and didn’t show any side-effects. Now this polyherbal combination “Astha-15” will undergo a phase III clinical trial with the most primary COVID-19 sites across India under the supervision of highly skilled physicians.

“We are conducting Human trials of our highly efficient Ayurvedic composition which can potentially help in curing COVID 19 patients. Successful human trials of our medicine will not only curtail the impact of the contagious virus all across the world but will also establish supremacy of Ayurveda, our ancient system of medicine over any other methods of healthcare” said Mr Sanjay Dalmia, Chairman, Dalmia Group of Companies. 

About Dalmia Health Care:

Dalmia Healthcare Limited (DHL), a Dalmia Group Company, has made foray into the healthcare business in the year 2000 and offers plant-based formulations (Ayurvedic/herbal) prepared through scientific validation followed by clinical trials undertaken by its research centre, Dalmia Centre for Research and Development   (DCRD).

The essence of pre-marketing efforts focuses on clinical trials compared and measured with those for various Allopathic drugs indicated for similar conditions. Extensive toxicological studies are conducted while formulating DHL products in order to ensure that our products are safe and devoid of adverse side-effects. All products of Dalmia Healthcare are manufactured and evaluated in accordance with the standards of modern medical parameters.

For more information, please contact:

Neha Bhatt
Dalmia Health Care
M: +91 9643816831

Sunil Singh
Firmus Vision
M: + 91 9899161154

mm

Kevin Taylor

Kevin has been a part of the journey ever since London Daily Post started. He has a special curiosity for events and stories revolving in and around the UK. Kevin brings an uncompromising form of journalistic standard for his audiences.

Next Post

The Demand for Physical Therapists is now Rising to Help in the Recovery of COVID-19 Patients

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

Chelsea (0) vs Wolves (0): Tuchel’s Chelsea era start with a draw

January 28, 2021

UK schools are not reopening till March

January 28, 2021

Investment Banker Florian Koschat on how to invest in 2021

January 28, 2021

What Skills Do You Need To Be A Social Media Manager?

January 28, 2021

Bader Al Safar, a Social Media Influencer, is Creating Content to Promote Streetwear and Sneakers

January 27, 2021

Top Work From Home Essentials For Small Businesses

January 27, 2021

Pengwin: Influencer Marketing Trends for 2021

January 27, 2021

The Benefits a Personal Trainer Provides With Alessandro Cassano

January 27, 2021

How to Pick the Right CBD Oil Products for Pets?

January 27, 2021

Determined to bring back harmony and connection back into families is Jessica Mcilveen, an unconventional family relationship expert.

January 27, 2021
  • Home
  • About
  • Team
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Cookie Policy

© 2019. London Daily Post.

No Result
View All Result
  • Home
  • About
  • Team
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Cookie Policy

© 2019. London Daily Post.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In